Lactate concentrations in the rectal lumen in patients in early septic shock

Acta Anaesthesiol Scand. 2010 Aug;54(7):827-32. doi: 10.1111/j.1399-6576.2010.02263.x. Epub 2010 Jun 15.

Abstract

Background: Previously, we observed that rectal luminal lactate was higher in non-survivors compared with survivors of severe sepsis or septic shock persisting >24 h. The present study was initiated to further investigate this tentative association between rectal luminal lactate and mortality in a larger population of patients in early septic shock.

Methods: A prospective observational multicentre study of 130 patients with septic shock at six general ICU's of university hospitals. Six to 24 h after the onset of septic shock, the concentration of lactate in the rectal lumen was estimated by a 4-h equilibrium dialysis. Dialysate concentrations of lactate were determined using an auto-analyser.

Results: The overall 30-day mortality was 32%, with age and Simplified acute physiology scores II and sequential organ failure assessment scores being significantly higher in non-survivors. In contrast, there were no differences in concentrations of lactate in the rectal lumen [2.2 (1.4-4.1) and 2.8 (1.6-5.1) mmol/l (P=0.34)] (medians and 25th-75th percentiles) or arterial blood [2.1 (1.4-4.2) and 2.0 (1.3-3.2) mmol/l (P=0.15)] between non-survivors and survivors. The rectal-arterial difference of the lactate concentration was higher in survivors. There were no differences in blood pressure, noradrenaline dose or central venous oxygen saturation between the groups.

Conclusion: In this prospective, observational study of unselected patients with early septic shock, there was no difference in the concentration of lactate in the rectal lumen between non-survivors and survivors.

Trial registration: Clinicaltrials.gov (no: NCT00197938).

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Biomarkers
  • Blood Pressure / physiology
  • Cohort Studies
  • Dialysis
  • Female
  • Humans
  • Lactic Acid / metabolism*
  • Male
  • Middle Aged
  • Norepinephrine / therapeutic use
  • Oxygen / blood
  • Predictive Value of Tests
  • Prospective Studies
  • Rectum / metabolism*
  • Shock, Septic / metabolism*
  • Shock, Septic / mortality
  • Survival
  • Treatment Outcome
  • Vasoconstrictor Agents / therapeutic use

Substances

  • Biomarkers
  • Vasoconstrictor Agents
  • Lactic Acid
  • Oxygen
  • Norepinephrine

Associated data

  • ClinicalTrials.gov/NCT00197938